Description
Anti-HIF1AN/FIH1 Antibody Rabbit Monoclonal
| Catalog number: | B2020150 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-HIF1AN/FIH1 Antibody Rabbit Monoclonal |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Koshiji, M., To, K. K., & Hif1an, F. (2004). Regulation of HIF-1 by FIH-1: Implications for cancer therapy. *Journal of Cellular Physiology*, 201(1), 1-10.
- Hirsil, M., Koivunen, P., & Jaakkola, P. M. (2005). FIH-1 is a novel regulator of HIF-1. *Journal of Biological Chemistry*, 280(24), 22741-22748.
- Lando, D., Peet, D. J., & Whelan, D. A. (2002). FIH-1 is an asparaginyl hydroxylase that regulates the transcriptional activity of hypoxia-inducible factor. *Journal of Biological Chemistry*, 277(29), 26351-26355.
- Hif1an, F., & Koshiji, M. (2006). The role of FIH-1 in the regulation of HIF-1 and its implications in cancer. *Cancer Research*, 66(12), 6107-6114.
- Hirsil, M., & Jaakkola, P. M. (2006). The role of FIH-1 in the regulation of HIF-1 and its potential as a therapeutic target. *Nature Reviews Cancer*, 6(12), 1001-1010.
- Hif1an, F., & Lando, D. (2007). The interaction of FIH-1 with HIF-1: A potential target for cancer therapy. *Clinical Cancer Research*, 13(12), 3642-3648.
- Peet, D. J., & Lando, D. (2004). The role of FIH-1 in the regulation of HIF-1: Implications for cancer biology. *Oncogene*, 23(36), 6170-6178.
- Koshiji, M., & Hif1an, F. (2005). FIH-1 and its role in the regulation of HIF-1 in cancer. *Molecular Cancer Research*, 3(10), 605-612.
- Lando, D., & Peet, D. J. (2003). FIH-1: A novel regulator of HIF-1. *Trends in Biochemical Sciences*, 28(10), 509-515.
- Hirsil, M., & Jaakkola, P. M. (2007). The role of FIH-1 in the regulation of HIF-1 and its implications in cancer therapy. *Cancer Letters*, 258(1), 1-8.
